AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+7.96%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$2.23B
AUM Growth
+$2.23B
(+4.2%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-4.66%
Top 10 Holdings %
Top 10 Hldgs %
29.81%
Holding
135
New
34
Increased
28
Reduced
32
Closed
28
Top Buys
| 1 |
Walmart
WMT
|
$53.4M |
| 2 |
O'Reilly Automotive
ORLY
|
$41M |
| 3 |
Ulta Beauty
ULTA
|
$39.7M |
| 4 |
Biogen
BIIB
|
$38.7M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$35M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$57.2M |
| 2 |
Merck
MRK
|
$43.5M |
| 3 |
Williams-Sonoma
WSM
|
$40.2M |
| 4 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$38.7M |
| 5 |
Lowe's Companies
LOW
|
$34.2M |
Sector Composition
| 1 | Healthcare | 63.34% |
| 2 | Consumer Staples | 15.6% |
| 3 | Consumer Discretionary | 14.64% |
| 4 | Technology | 2.6% |
| 5 | Industrials | 1.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $79.6M | 2.71% | 30,134,285 +120,000 | +0.4% | +$317K |
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $78.5M | 2.67% | 3,120,000 -80,000 | -3% | -$2.01M |
|
3
Vanda Pharmaceuticals
VNDA
$279M
| $70.9M | 2.41% | 5,399,277 -50,723 | -0.9% | -$666K |
|
4
Lantheus
LNTH
$3.73B
| $70.1M | 2.39% | 5,200,000 +364,000 | +8% | +$4.91M |
|
5
Bristol-Myers Squibb
BMY
$96B
| $64.3M | 2.19% | 1,036,000 +36,000 | +4% | +$2.23M |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $63.8M | 2.17% | 132,000 +48,000 | +57% | +$23.2M |
|
|
7
Biogen
BIIB
$19.4B
| $63.2M | 2.15% | 258,000 +158,000 | +158% | +$38.7M |
|
|
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $59.7M | 2.03% | 272,000 +104,000 | +62% | +$22.8M |
|
9
Incyte
INCY
$16.5B
| $59M | 2.01% | 678,000 +42,000 | +7% | +$3.65M |
|
|
10
Enanta Pharmaceuticals
ENTA
$180M
| $57.1M | 1.94% | 1,356,000 +832,000 | +159% | +$35M |
|
|
11
Walmart
WMT
$774B
| $53.4M | 1.82% | +370,225 | New | +$53.4M |
|
|
BHVN
12
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $49M | 1.67% | 572,000 -328,000 | -36% | -$28.1M |
|
13
Five Below
FIVE
$8B
| $46.9M | 1.6% | 268,185 +143,985 | +116% | +$25.2M |
|
14
Alkermes
ALKS
$4.78B
| $44.2M | 1.5% | 2,216,000 +92,000 | +4% | +$1.84M |
|
15
PTC Therapeutics
PTCT
$3.92B
| $43.7M | 1.49% | 716,000 -8,000 | -1% | -$488K |
|
16
Energizer
ENR
$1.88B
| $41.3M | 1.4% | 978,000 -700,000 | -42% | -$29.5M |
|
|
17
O'Reilly Automotive
ORLY
$88B
| $41M | 1.39% | +90,583 | New | +$41M |
|
|
18
Ulta Beauty
ULTA
$22.1B
| $39.7M | 1.35% | +138,304 | New | +$39.7M |
|
19
Central Garden & Pet Class A
CENTA
$2.08B
| $38.7M | 1.31% | 1,064,000 +92,000 | +9% | +$3.34M |
|
|
BLUE
20
DELISTED
bluebird bio
BLUE
| $38M | 1.29% | 878,000 +78,000 | +10% | +$3.38M |
|
21
Campbell Soup
CPB
$9.52B
| $37.1M | 1.26% | 768,000 -148,000 | -16% | -$7.16M |
|
22
Madrigal Pharmaceuticals
MDGL
$9.76B
| $35.1M | 1.19% | 316,000 +38,000 | +14% | +$4.22M |
|
23
UnitedHealth
UNH
$281B
| $35.1M | 1.19% | 100,000 -50,000 | -33% | -$17.5M |
|
24
Catalyst Pharmaceutical
CPRX
$2.52B
| $33.4M | 1.14% | 10,000,000 | – | – |
|
25
Frontdoor
FTDR
$4.43B
| $32.9M | 1.12% | 656,000 -216,000 | -25% | -$10.8M |
|